Australian supplement company Blackmores facing potential class action lawsuit
Dominic Noonan-O'Keeffe began taking Blackmores supplements in May 2023 to support his health, ahead of the birth of his first child.
Unaware the magnesium product contained potentially 'toxic' levels of vitamin B6, he claims he soon developed severe symptoms – including fatigue, headaches, muscle spasms, heart palpitations, and loss of sensation, according to Polaris lawyers.
Doctors later diagnosed him with neuropathy linked to excessive B6 intake.
Despite stopping in early 2024, Mr Noonan-O'Keeffe claims he continues to suffer daily from nerve pain and other symptoms.
Polaris Lawyers – who are representing Mr Noonan-O'Keeffe, the lead plaintiff in the potential class-action – allege they later discovered the magnesium product contained about 29 times the recommended daily intake of vitamin B6.
Mr Noonan-O'Keeffe claims he suffered lasting health impacts after taking Blackmores Magnesium+. Picture: Supplied
Polaris Lawyers is now investigating a proposed class action against Blackmores for the excessive B6 levels in their vitamin supplements.
'It's alarming to walk down the vitamin aisle of any chemist in Australia and see vitamin supplements containing levels of B6 which are far and above the recommended daily intake,' Polaris Lawyers Founder and Principal Nick Mann said.
'What happened to Dominic is tragic, but he is not alone – we are aware of reports that excessive levels of B6 in over-the-counter supplements may have caused lasting injuries to hundreds of Australians.
'Polaris Lawyers is currently investigating a class action on behalf of anyone who has suffered injuries as a result of excessive levels of B6 as a result of taking Blackmores vitamin supplements.'
Blackmores is one of the country's biggest supplement providers. Picture: Supplied
In an interim decision report released in June, the TGA acknowledged no clear consensus on a safe vitamin B6 level that fully prevents peripheral neuropathy.
The decision proposed rescheduling products containing over 50mg per day as 'Pharmacist Only Medicines.'
A Blackmores spokesperson said they were aware of the TGA's proposed changes.
'At Blackmores, we are committed to the highest standards of product quality and consumer safety. All our products, including those containing Vitamin B6, are developed in strict accordance with the regulatory requirements of the Therapeutic Goods Administration (TGA),' the spokesperson said.
'This includes compliance with maximum permitted daily doses and the inclusion of mandated warning statements.
'We acknowledge the interim decision issued by the TGA and we will ensure full compliance with its final determination.'
Amelia Swan
Journalist
Amelia Swan joined News Corp as a cadet reporter in 2024.
Amelia Swan
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ABC News
8 minutes ago
- ABC News
Thousands in NSW could be modern slavery victims, but one scheme may worsen the situation
Australia faces a potential escalation in cases of modern slavery, the NSW anti-slavery commissioner warns, as sectors such as aged care become increasingly reliant on temporary migrant workers. James Cockayne, who was appointed to the role in 2022, estimates more than 16,000 people in NSW are living in modern slavery conditions. Each week on average, his office receives four reports of slavery — through the 1800 FREEDOM hotline — but he fears many more cases go unreported. Some of the most common examples of modern slavery include forced labour, domestic and sexual servitude, debt bondage, deceptive recruiting and even human trafficking. Dr Cockayne said it was a "very hidden" issue, not widely recognised by the general public. "We all have the notion that slavery was abolished a long time ago and it was abolished as a legal construct, but it's still happening," he said. While there is evidence of slavery in "a wide array of industries", Dr Cockayne has singled out aged care as an emerging area of concern. This is because the Pacific Australia Labour Mobility (PALM) scheme — predominantly used to fill labour shortages in horticulture and meat processing — is now expanding into aged care. The PALM scheme allows eligible businesses to hire workers from Pacific Island nations on temporary visas, but there have been widespread concerns it puts migrants at risk of exploitation. Dr Cockayne said he was concerned the aged care sector had "not adequately" prepared for this risk. "What we've seen in other places, where there's been a move to rely on temporary migrant workers, is a significant increase in modern slavery. "In the UK, when temporary migrant workers were introduced into the healthcare sector, there was a doubling in one year of the number of reports of modern slavery from that sector." The peak body for the aged care sector, Ageing Australia, has been contacted for a response. NSW has often been touted as a leader in the fight against slavery — it was the first, and remains the only state or territory in Australia, to appoint an anti-slavery commissioner. But Dr Cockayne said NSW had been lagging other states in cracking down on "dodgy labour hire companies". He called for a licensing scheme to provide better oversight. "New South Wales is one of the only jurisdictions in the country that doesn't have licensing of labour hire companies," Dr Cockayne said. "That's certainly an area we'd like to see the government looking very hard at, and thinking about how they can strengthen regulation in that space." In a statement, a spokesperson for the NSW Government said it has been "actively engaged" with the Commonwealth and other states and territories about establishing a national licensing scheme. "Such a scheme would cover eligible workers in NSW," the statement said. "The NSW Government recognises the serious risk of exploitation and modern slavery faced by temporary migrant workers, particularly in rural and regional areas." It is not just within NSW that Dr Cockayne wants to see change — he argues anti-slavery policies adopted here could have global consequences. His office is focusing heavily on government agencies can ensure the products and services they obtain are not the product of slavery in other countries. Dr Cockayne argues NSW could be a world leader in eliminating this risk. "If you take defence spending out of the picture, New South Wales is actually the largest purchaser of goods and services in the entire Southern Hemisphere," he said. "It has a lot of commercial muscle to change the practices of businesses that produce goods and services with modern slavery." Dr Cockayne acknowledges the issue could become increasingly difficult to navigate, given the growing demand for solar panels and electric vehicles — both of which have been linked with slave labour. "The reality is that in certain contracts, for example around solar panels, it's very hard indeed to find slave-free supply," he said. However, he said in some cases it might be counter-productive to cut commercial ties with suppliers that are linked to slavery. "So we have to think about what the underlying policy goal is here," he said. "Is it to not be associated with slavery? Or is it to actually use the relationship with the supplier to ensure that the goods and services are made in a way that doesn't rely on slavery?" With his five-year term as NSW anti-slavery commissioner now past the halfway mark, Dr Cockayne said he had plenty of unfinished business. He now also has a national counterpart — Chris Evans, who last year was appointed as the first Australian anti-slavery commissioner — and is in regular contact on cross-border issues. "I do hope that we're able to demonstrate that we're driving down the frequency with which people are drawn into these really tragic horrible life events," Dr Cockayne said. "But we will have to stay vigilant because there will always be vulnerable people operating in circumstances where the institutional safeguards don't protect them adequately from exploitation."
News.com.au
8 minutes ago
- News.com.au
Disorder to go: Tackling the deadliest psychological illnesses no one is talking about
Eating disorders are among the deadliest mental health disorders Prevalence among kids 10-19 has almost doubled in last decade Eating disorders cost Australia $67 billion every year in economic and wellbeing losses We've all had those thoughts. Maybe I should cut down on the beers. I guess I should go for walk. I should probably eat better. Maybe I could stand to lose a little extra weight here and there. Body dissatisfaction is a pretty universal experience, but for many it's a temporary thought, a passing moment of discomfort quickly forgotten. For too many people, especially young people, those uncomfortable, niggling thoughts have become a daily mantra they can't ignore – and it's almost certainly killing them. A matter of life and death Eating disorders are widely acknowledged as the deadliest psychological issues a person can be diagnosed with. That fact is further complicated by comorbidity; a startling 90% of people with eating disorders also have depression, with two thirds simultaneously suffering from an anxiety disorder. While that combination is deadly on its own – someone with Anorexia Nervosa is 18-times more likely to die by suicide, and those with Bulimia Nervosa seven-times more likely – the leading cause of death among people with severe eating disorders is cardiovascular damage. The compulsions that come with eating disorders starve the body of nutrients and energy, damaging everything from the heart and bones to the digestive and immune systems. Even worse, the growing epidemic of eating disorders is becoming entrenched in schools and on social media, affecting younger and younger people during vulnerable periods of social and physical growth. 'Eating disorders among children and young people aged 10-19 has almost doubled in the last decade,' said Dr Jim Hungerford, CEO of eating disorder not-for-profit Butterfly. 'Every month 100 people die from, and 10,000 develop, an eating disorder, and it is critical that the government invest to stop this emerging crisis in eating disorders.' A national crisis Deloitte's report, Paying the Price, underscores the heavy toll eating disorders take not just on individuals and families, but on our wider society, too. Eating disorders cost Australia $67 billion every year in economic and wellbeing losses. In February, Minister for Health Mark Butler called eating disorders 'a national crisis' – the federal government has earmarked $70 million in grants for programs to research and treat them. At the moment, treatment for eating disorders is almost entirely based on psychological interventions like cognitive behavioural therapy, family therapy, or more structured and specialised treatments like the Maudsley model of anorexia treatment for adults (MANTRA). These treatments often have good outcomes; some 60% of anorexia nervosa patients receiving enhanced CBT treatments recover to a healthy weight. Unfortunately, there are few alternatives for the 40% of patients that don't respond well to psychological intervention. There are currently no approved pharmacological treatment options at all, although some doctors treat their patients off-label with drugs approved for other mental health conditions. More direct types of intervention are quite recent – researchers are exploring everything from deep brain stimulation to hormone therapies and psychedelics like ketamine or psilocybin. It's a new frontier of medicine, led almost entirely by a handful of intrepid pioneers scattered across the globe. Hitting reset on neural pathways Interest in psychedelic compounds as a basis for psychological treatment has gained a lot of attention in recent years. Medicinal compounds based on marijuana, MDMA, ketamine and psilocybin or psilocin from magic mushrooms have been touted as miracle drugs set to revolutionise the treatment of mental health disorders. While we haven't obtained those lofty goals just yet, psychedelic compounds are already showing an incredible amount of promise in mental health disorders resistant to traditional psychological or medical intervention. The research is still thin on the ground, but it's thought these compounds have a 'resetting' effect on neurological pathways, disrupting habitual ingrained behaviours and encouraging new connections between different regions of the brain. You can imagine them a bit like a cleansing flood, washing away the old, worn and rutted pathways of the brain and offering a chance to forge new ones in their place. Companies such as Tryptamine Therapeutics (ASX:TYP) are working to transform these powerful compounds – once the realm of medicine men and shamans – into something the TGA or FDA can get behind. TYP is developing two such medicines; an intravenous (IV) infused synthetic psilocin compound, and an oral synthetic psilocybin compound, both designed to offer precise dosing options without adverse effects. The company's main focuses are binge eating disorder (BED) and illnesses that induce chronic pain like fibromyalgia and irritable bowel syndrome. BED is the most common eating disorder in the US and the second most common in Australia, representing a high unmet need. Tryptamine is at the clinical assessment stage with its TRP-8803 IV infusion, currently engaged in a safety and efficacy trial in partnership with Swinburne University of Technology in Melbourne. The company is dosing 12 adult patients suffering from BED with its TRP treatment alongside simultaneous psychotherapy sessions. The oral version of the drug has already shown promise in treating BED, reducing daily binge eating episodes by an average of 80.4% in a phase II trial with the University of Florida. All patients experienced a reduction in episodes of at least 60% from baseline, with improvements in anxiety and depression scores as well. While the open-label study had a limited patient population with only five participants, it's nonetheless a very promising start. Overcoming psychedelic adverse effects One of the challenges in bringing psychedelic medicines to market is also a strength: the altered cognitive state they induce in patients. Both Tryptamine Therapeutics and its Israeli brethren Shortwave Life Sciences are working to unlock the therapeutic benefits of psychedelics while side-stepping the more intense adverse effects they can illicit in people. They're attempting to take the guesswork out of dosage and adverse impact by producing synthetic versions of psilocin and psilocybin compounds that are highly controlled, offering more predictable outcomes. Shortwave is focused mostly on Anorexia Nervosa, one of the deadliest eating disorders. The company is developing an oral drug combining psilocybin with a beta carboline, a type of tryptamine compound associated with neurotransmitters like serotonin and norepinephrine that directly influence mood. Shortwave is still in the pre-clinical stages with its drug combination, but early studies are indicating a good safety profile and active metabolisation. The company has partnered with the Sheba Medical Centre, considered a leading medical institution and eating disorder centre in Israel, to conduct an investigator-initiated, open-label, phase II study. The trial will investigate the safety and feasibility of psilocybin-assisted psychotherapy for the treatment of anorexia nervosa, the first of its kind in Israel. Taking a molecular approach Not all pharmacological interventions being developed for eating disorders are based on psychedelics, but they share a distinct emphasis on resetting or rewiring disordered neurological pathways. Courage Therapeutics, a spinout of the University of Michigan, has just secured US$7.8 million to advance two drug development programs designed to tackle obesity and restrictive eating disorders. Head researcher Roger Cone identified two proteins thought to play a part in regulating energy balance and food intake – melanocortin 3 receptor and melanocortin 4 receptor (MC3R and MC4R). Courage Therapeutics is focusing on leveraging these proteins to directly hack into neurological circuits in the hypothalamus. Also at the pre-clinical stage, animal studies in mammals have shown great promise in influencing feeding behaviours and weight management. A rat animal model using CRISPR technology to induce MC3R deficiency showed a significant reduction in both body weight and decreased food intake, while those with an MC4R deficiency increased food intake and gained body weight compared to the control group. A long path ahead While research into pharmacological interventions for eating disorders is still in very early stages, the results so far have been incredibly encouraging. The science seems sound, but proving these treatments are not only effective but safe and predictable will take years of clinical trials and testing. The Butterfly Foundation is calling for urgent investment in eating disorder research as the number of people suffering from them rises year by year. 'We were incredibly disappointed that there was zero new funding for eating disorder prevention or treatment in the Australian government's 2025-26 budget announcement on March 25,' Dr Hungerford said, 'nor in the budget response from the Coalition.' 'It is clear from latest research that people in Australia want to know why. Without government investment in prevention, the consequences will be catastrophic. 'The time for talk is over, the time for action for the more than 1 million people living with an eating disorder is now.' At Stockhead, we tell it like it is. While Tryptamine Therapeutics is a Stockhead advertiser, it did not sponsor this article.
ABC News
8 minutes ago
- ABC News
Smartphones affect young people's mental health so are dumbphones the answer?
How old were you when you got your first smartphone? For many Aussies born in the past two generations, such as Ekaager, 16, Kian, 15, Daiwik, 16, and Jiujiu, 15, smartphones have been a part of life since early childhood. "I think I was 12 or 11, around that age," Ekaager said. Kian said: "I think I was like 10 or 11." "I was definitely 12," Daiwik said. "Yeah, something like 12," Jiujiu said. A global 2024 study commissioned by tech company Human Mobile Devices (HMD) found that young people were being given smartphones at an average age of 11 years old. In some cases, smartphones were being introduced as young as three years old. This early introduction to smartphones has "dramatically reshaped childhood and adolescence", according to new research published in the Journal of Human Development and Capabilities. Using survey data from more than 100,000 18 to 24-year-olds, researchers found that the younger those surveyed got a smartphone, from the age of 13 and under, the worse their mental health was. The specific symptoms reported included suicidal thoughts, aggression and detachment from reality. When asked what they thought about the findings, the teens BTN High spoke to said it made sense. "Especially because a lot of the platforms I use, like Instagram, can be a little addictive … it's hard for me to put it down," Lily, 15, said. "I remember in year 10 I was really at my lowest and I think that social media was the significant contributing factor to it," Eric, 17, said. Harsimrat, 15, said it was not just the mental health impacts. "There are many issues like attention span," he said. "Because even myself, sometimes in class, I just doze off because I just can't spend that much time looking at the board." Child psychologist Michael Carr-Gregg led a review into phone use in schools in 2018, which has since resulted in a nationwide ban on phones in public schools. Dr Carr-Gregg said that while the study's results were new, it was something experts had suspected. "I think it was 2007, the Apple iPhone was launched, we started replacing a play-based childhood with a screen-based childhood," he said. "And right across the western world … we have seen an increase in depression and anxiety and self-harm. "Therefore, this is just a confirmation of what we already knew." The study also recommends "graduated access restrictions," keeping anyone under 13 from having a smartphone, which Dr Carr-Gregg approves of. "Smartphones tend to be a distraction. They do interfere with sleep," he said. "They do create, I think, avenues for cyberbullying, extortion, those sorts of things. "So, for me, the result is from the university of the bleeding obvious, which is why I think a restriction, a delay, on young people having smartphones is sensible." Some of the teens BTN High spoke to also agreed it was a good idea. Lachlan, 15, said: "It's just probably for the better in future life." Others, like Angus, 16, weren't keen on it. "Thirteen is past that age where we … enter high school," he said. "I feel like phones are a big part of socialising and that sort of connection that many people rely on. "So I think it's a bit harsh." A "dumbphone", also known as a feature phone, is a basic device with limited functionality. No internet browsing, no apps, no complex multimedia functions – and that's the appeal for some young people, such as 18-year-old Jameson Butler. She is the co-founder of The Luddite Club, a group of teens in New York dedicated to promoting the conscious consumption of technology. "My sleep schedule was off the charts," Jameson said. "I was staying up until 3am. I was staying in my room, you know, on my phone. "And I just felt bad … I didn't feel there were any options or ways to combat that." Jameson said after ditching her smartphone, life improved. "I'm more present at family dinners. I do my schoolwork faster, I have better grades, I've become a lot less scatterbrained, and I've just become a lot more driven and ambitious." The Luddite Club has been gaining popularity. Jameson told the ABC's Brain Rot Podcast that she was seeing Luddite Clubs starting to pop up in Florida and Philadelphia, and she had even had some enquiries from Australia. While the dumbphone trend has been growing in the US and Europe, I want to find out if it is something young Aussies are doing too. After sitting at the University of Adelaide for more than an hour, no young people I spoke to even knew of anyone who used a dumbphone. "Yeah, this is too old," said one student. Harsimrat agreed, saying, "No, that's back in the old days." None of Dr Carr-Gregg's clients are on board either. "I can honestly put my hand on my heart and say I don't have one who's doing that," he said. "Once you've got a smartphone, I think the likelihood of you going back to a dumbphone is very, very small. "And that's because really the way in which my clients communicate with one another these days is through social media. "And therefore the smartphone is absolutely essential." Alex, 17, said a loss of connection might be putting young Aussies off. "I think there's a big fear of missing out," he said. "It's like if people aren't connected with their screens and social media and stuff, they … can't see what other people are posting, [what] they're doing on it. "A lot of my friends live in different places throughout the world, and I wouldn't be able to call them on a phone like that," Lily said. Despite social media being a major part of smartphone use, some teens, such as Alex, reckon Australia's incoming ban for under-16s won't change too many minds. "There are other things you can do on [smartphones], like games and stuff, even though you don't have social media," he said. Simar, 16, said in her case, a smartphone was handy for her parents to know her location because she had to walk to school by herself. Ekaager thinks young people will keep their smartphones and find ways around the ban. Nevertheless, Ekaager was open to giving the dumbphone trend a go, as was Eric. "Maybe I should with the current exam season coming up," Eric said. Lily agreed that it would be "a nice experiment to try". And Alex said, "I'd probably struggle to, but I would maybe give it a try just to improve my mental health."
